UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
Form 10-C/A
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 and Rule 13a-17 or 15d-17 thereunder
Purepac, Inc.
(Exact name of issuer as specified in charter)
200 Elmora Avenue, Elizabeth, New Jersey 07207
(Address of principal executive offices)
(908) 527-9100
(Issuer's telephone number, including area code)
1. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of security: Common Stock
2. Number of shares outstanding before the change: 12,615,223
3. Number of shares outstanding after the change: 15,125,539
4. Effective date of change: February 29, 1996
5. Method of change: Acquisition
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.)
Give brief description of transaction: The Registrant acquired from
its majority stockholder, Faulding Holdings Inc. ("Faulding"), all
of the capital stock of each of Faulding Puerto Rico, Inc., a
Delaware corporation, Faulding Pharmaceutical Co., a Delaware
corporation, and Faulding Medical Device Co., a Delaware corporation,
each a wholly-owned subsidiary of Faulding (collectively, the
"Acquired Companies"), for 2,510,316 shares of the Registrant's
Common Stock, subject to adjustment as a result of an audit of the
net asset value of the Acquired Companies at February 29, 1996.
II. CHANGE IN NAME OF ISSUER
1. Name prior to change: Purepac, Inc.
2. Name after change: Faulding Inc.
3. Effective date of charter amendment changing name: February 29, 1996
4. Date of shareholder approval of change, if required: February 29, 1996
Date: March 14, 1996 /s/Richard F. Moldin
--------------------
Richard F. Moldin
President and
Chief Executive Officer
